Xtandi Approved for Nonmetastatic Castration-Sensitive Prostate Cancer

Retrieved on: 2023-11-21 16:07:11

Tags for this article:

Nonsteroidal antiandrogens

Prostate cancer

Biochemical recurrence

Medivation

Xtandi

Click the tags to see associated articles and topics

Xtandi Approved for Nonmetastatic Castration-Sensitive Prostate Cancer. View article details on HISWAI: https://www.cancertherapyadvisor.com/home/cancer-topics/prostate-cancer/xtandi-gains-approval-for-nonmetastatic-castration-sensitive-prostate-cancer/

Excerpt

Pfizer and Astellas' Xtandi® approved by US FDA in earlier prostate cancer treatment setting. News release. Pfizer and Astellas Pharma. November ...

Article found on: www.cancertherapyadvisor.com

View Original Article